Business · Companies · 3 hrs ago
Tilray reports record sales after losing 99% of its market value
Tilray reported record quarterly revenue of $257.1 million on the 8th, surprising investors.
The company produces medical cannabis, including at a facility in Cantanhede, Portugal.
Its share price fell from $300 to $3 in three years, as its market value lost 99%.
That decline continued for three years, and some Wall Street investors treated the company as finished.
Tilray found a route back through beer, according to the account of its recovery.
The new sales record matters because it shows the company has returned to growth after a steep collapse.
The information provided does not say what Tilray plans to do next.
Tilray reported record quarterly sales of $257.1 million, according to Maeil Business.
The company’s share price fell from $300 to $3 over three years, wiping out 99% of its market value.
The decline continued for three years, and Wall Street viewed the company as finished.
Tilray announced its record sales on the 8th, surprising the market.
The article identifies Tilray as a medical cannabis producer with a European production site in Cantanhede, Portugal.
- Who
- Tilray, a medical cannabis producer.
- What
- It reported record quarterly sales of $257.1 million.
- When
- The company announced the results on the 8th. The article was published on October 17, 2026.
- Where
- Not stated
- Why
- Not stated
This story does not have two clearly opposing sides.
Tilray’s share price fell from $300 to $3 over three years, and the company lost 99% of its market value.
The article says the downward trend continued for three years.
Tilray announced quarterly sales of $257.1 million, a record.
- Quarterly sales
- $257.1 million, a record
- Market value lost
- 99%
- Share price decline
- From $300 to $3 over three years
- European production site
- Cantanhede, Portugal